ONTRALFY
Live / Applied — Third extension granted (statement of use) (as of 05 Oct 2025)
What this means for you
Not registered yet, but its 14 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97888695
- Mark type
- Stylized text
- Filed
- 14 Apr 2023
- Published for opposition
- 19 Dec 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations for the treatment and prevention of seizures and spasms
Owner
- Fidelity Biopharma Co., New Haven, CT, US
- Fidelity Biopharma Co., New Haven, CT, US
Prosecution history
- 18 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 06 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Oct 2025 — SOU EXTENSION 3 GRANTED
- 05 Oct 2025 — SOU EXTENSION 3 FILED
- 05 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Apr 2025 — SOU EXTENSION 2 GRANTED
- 08 Apr 2025 — SOU EXTENSION 2 FILED
- 08 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Oct 2024 — SOU EXTENSION 1 GRANTED
- 07 Oct 2024 — SOU EXTENSION 1 FILED
- 07 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 09 Apr 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Feb 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED